AAAAAA
Results: 1-25/33
Authors:
MESSICK CR
MAMDANI M
MCNICHOLL LR
DANZIGER LH
RODVOLD KA
CONDON RE
WALKER AP
EDMISTON CE
Citation: Cr. Messick et al., PHARMACOECONOMIC ANALYSIS OF AMPICILLIN-SULBACTAM VERSUS CEFOXITIN INTHE TREATMENT OF INTRAABDOMINAL INFECTIONS (VOL 18, PG 175, 1998), Pharmacotherapy, 18(3), 1998, pp. 662-662
Authors:
MESSICK CR
MAMDANI M
MCNICHOLL IR
DANZIGER LH
RODVOLD KA
CONDON RE
WALKER AP
EDMISTON CE
Citation: Cr. Messick et al., PHARMACOECONOMIC ANALYSIS OF AMPICILLIN-SULBACTAM VERSUS CEFOXITIN INTHE TREATMENT OF INTRAABDOMINAL INFECTIONS, Pharmacotherapy, 18(1), 1998, pp. 175-183
Authors:
PENZAK SR
GUBBINS PO
RODVOLD KA
HICKERSON GL
Citation: Sr. Penzak et al., THERAPEUTIC DRUG-MONITORING OF VANCOMYCIN IN A MORBIDLY OBESE PATIENT, Therapeutic drug monitoring, 20(3), 1998, pp. 261-265
Authors:
CHUCK SK
KILLIAN AD
LUER M
DANZIGER LH
RODVOLD KA
Citation: Sk. Chuck et al., PENETRATION OF VANCOMYCIN (V) INTO CEREBROSPINAL-FLUID (CSF) OF VENTRICULOSTOMY PATIENTS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 41-41
Authors:
GOTFRIED MH
KILLIAN AD
SERVI RJ
DANZIGER LH
RODVOLD KA
Citation: Mh. Gotfried et al., IV CEFUROXIME PLUS ORAL CLARITHROMYCIN OR IV ERYTHROMYCIN FOR THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN HOSPITALIZED-PATIENTS - A PILOT-STUDY, Clinical drug investigation, 14(1), 1997, pp. 23-34
Authors:
RODVOLD KA
EVERETT JA
PRYKA RD
KRAUS DM
Citation: Ka. Rodvold et al., PHARMACOKINETICS AND ADMINISTRATION REGIMENS OF VANCOMYCIN IN NEONATES, INFANTS AND CHILDREN, Clinical pharmacokinetics, 33(1), 1997, pp. 32-51
Authors:
PENDLAND SL
KILLIAN AD
WOODWARD JG
RODVOLD KA
Citation: Sl. Pendland et al., IN-VITRO ACTIVITY OF A NEW ORAL STREPTOGRAMIN, RPR-106972, ALONE AND IN COMBINATION WITH RIFAMPICIN OR CIPROFLOXACIN AGAINST LEGIONELLA SPP, Journal of antimicrobial chemotherapy, 39(5), 1997, pp. 651-653
Authors:
GENTRY CA
RODVOLD KA
NOVAK RM
HERSHOW RC
NADERER OJ
Citation: Ca. Gentry et al., RETROSPECTIVE EVALUATION OF THERAPIES FOR STAPHYLOCOCCUS-AUREUS ENDOCARDITIS, Pharmacotherapy, 17(5), 1997, pp. 990-997
Authors:
RODVOLD KA
DANZIGER LH
QUINN JP
Citation: Ka. Rodvold et al., SINGLE DAILY DOSES OF AMINOGLYCOSIDES - COMMENTARY, Lancet, 350(9089), 1997, pp. 1412-1412
Authors:
RODVOLD KA
GOTFRIED MH
DANZIGER LH
SERVI RJ
Citation: Ka. Rodvold et al., INTRAPULMONARY STEADY-STATE CONCENTRATIONS OF CLARITHROMYCIN AND AZITHROMYCIN IN HEALTHY ADULT VOLUNTEERS, Antimicrobial agents and chemotherapy, 41(6), 1997, pp. 1399-1402
Authors:
KANYOK TP
KILLIAN AD
RODVOLD KA
DANZIGER LH
Citation: Tp. Kanyok et al., PHARMACOKINETICS OF INTRAMUSCULARLY ADMINISTERED AMINOSIDINE IN HEALTHY-SUBJECTS, Antimicrobial agents and chemotherapy, 41(5), 1997, pp. 982-986
Authors:
OCCHIPINTI DJ
PENDLAND SL
SCHOONOVER LL
RYPINS EB
DANZIGER LH
RODVOLD KA
Citation: Dj. Occhipinti et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF 2 MULTIPLE-DOSE PIPERACILLIN-TAZOBACTAM REGIMENS, Antimicrobial agents and chemotherapy, 41(11), 1997, pp. 2511-2517
Authors:
KILLIAN AD
RODVOLD KA
HERMANN DJ
PLANK G
Citation: Ad. Killian et al., POPULATION PHARMACOKINETICS (PPK) OF TOBRAMYCIN (T) IN ADULTS WITH LEUKEMIA, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 69-69
Authors:
SCHOONOVER L
OCCHIPINTI DJ
RODVOLD KA
DANZIGER LH
Citation: L. Schoonover et al., PIPERACILLIN TAZOBACTAM - A NEW BETA-LACTAM BETA-LACTAMASE INHIBITOR COMBINATION/, The Annals of pharmacotherapy, 29(5), 1995, pp. 501-514
Authors:
SCHUMOCK GT
RABER SR
CRAWFORD SY
NADERER OJ
RODVOLD KA
Citation: Gt. Schumock et al., NATIONAL SURVEY OF ONCE-DAILY DOSING OF AMINOGLYCOSIDE ANTIBIOTICS, Pharmacotherapy, 15(2), 1995, pp. 201-209
Authors:
RODVOLD KA
GENTRY CA
PLANK GS
KRAUS DM
NICKEL E
GROSS JR
Citation: Ka. Rodvold et al., BAYESIAN FORECASTING OF SERUM VANCOMYCIN CONCENTRATIONS IN NEONATES AND INFANTS, Therapeutic drug monitoring, 17(3), 1995, pp. 239-246
Authors:
GENTRY CA
RODVOLD KA
Citation: Ca. Gentry et Ka. Rodvold, HOW IMPORTANT IS THERAPEUTIC DRUG-MONITORING IN THE PREDICTION AND AVOIDANCE OF ADVERSE REACTIONS, Drug safety, 12(6), 1995, pp. 359-363
Authors:
RUSHING DA
RABER SR
RODVOLD KA
PISCITELLI SC
FLANK GS
TEWKSBURY DA
Citation: Da. Rushing et al., THE EFFECTS OF CYCLOSPORINE ON THE PHARMACOKINETICS OF DOXORUBICIN INPATIENTS WITH SMALL-CELL LUNG-CANCER - REPLY, Cancer, 75(5), 1995, pp. 1215-1216
Authors:
DANZIGER LH
PISCITELLI SC
OCCHINTI DJ
RESNICK DJ
RODVOLD KA
Citation: Lh. Danziger et al., STEADY-STATE PHARMACOKINETICS OF CEFOPERAZONE AND SULBACTAM IN PATIENTS WITH ACUTE APPENDICITIS, The Annals of pharmacotherapy, 28(6), 1994, pp. 703-707
Authors:
GENTRY CA
PALOUCEK FP
RODVOLD KA
Citation: Ca. Gentry et al., PREDICTION OF ACETAMINOPHEN CONCENTRATIONS IN OVERDOSE PATIENTS USINGA BAYESIAN PHARMACOKINETIC MODEL, Journal of toxicology. Clinical toxicology, 32(1), 1994, pp. 17-30
Authors:
BERTINO JS
RODVOLD KA
DESTACHE CJ
Citation: Js. Bertino et al., COST CONSIDERATIONS IN THERAPEUTIC DRUG-MONITORING OF AMINOGLYCOSIDES, Clinical pharmacokinetics, 26(1), 1994, pp. 71-81
Authors:
VANCEBRYAN K
ROTSCHAFER JC
GILLILAND SS
RODVOLD KA
FITZGERALD CM
GUAY DRP
Citation: K. Vancebryan et al., A COMPARATIVE-ASSESSMENT OF VANCOMYCIN-ASSOCIATED NEPHROTOXICITY IN THE YOUNG VERSUS THE ELDERLY HOSPITALIZED PATIENT, Journal of antimicrobial chemotherapy, 33(4), 1994, pp. 811-821
Authors:
RODVOLD KA
ROTSCHAFER JC
GILLILAND SS
GUAY DRP
VANCEBRYAN K
Citation: Ka. Rodvold et al., BAYESIAN FORECASTING OF SERUM VANCOMYCIN CONCENTRATIONS WITH NON-STEADY-STATE SAMPLING STRATEGIES, Therapeutic drug monitoring, 16(1), 1994, pp. 37-41
Authors:
FISH DN
GOTFRIED MH
DANZIGER LH
RODVOLD KA
Citation: Dn. Fish et al., PENETRATION OF CLOARITHROMYCIN INTO LUNG TISSUES FROM PATIENTS UNDERGOING LUNG RESECTION, Antimicrobial agents and chemotherapy, 38(4), 1994, pp. 876-878
Authors:
GENTRY CA
RODVOLD KA
PLANK G
KRAUS DM
GROSS JR
NICKEL E
Citation: Ca. Gentry et al., A BAYESIAN PHARMACOKINETIC (PK) MODEL FOR GENTAMICIN (G) IN NEONATES AND INFANTS (N I)/, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 177-177